JD Vance Predicts: Wall Street vs. Trump & Your Money

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Christopher Maggiore Biography and Net Worth

Director of ZIVO Bioscience

Mr. Maggiore was appointed to the Board of Directors on August 28, 2013. He has a successful track record in entrepreneurship, with over 25 years of experience in the areas of real estate development and building and management of businesses. Mr. Maggiore currently owns and manages a portfolio of diverse businesses and investments.

What is Christopher D. Maggiore's net worth?: The estimated net worth of Christopher D. Maggiore is at least $2.84 million as of September 14th, 2022. Mr. Maggiore owns 135,050 shares of ZIVO Bioscience stock worth more than $2,836,050 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Maggiore may own. Learn More about Christopher D. Maggiore's net worth.
How do I contact Christopher D. Maggiore?: The corporate mailing address for Mr. Maggiore and other ZIVO Bioscience executives is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. ZIVO Bioscience can also be reached via phone at (248) 452-9866 and via email at [email protected]. Learn More on Christopher D. Maggiore's contact information.
Has Christopher D. Maggiore been buying or selling shares of ZIVO Bioscience?: Christopher D. Maggiore has not been actively trading shares of ZIVO Bioscience during the last ninety days. Most recently, on Wednesday, September 14th, Christopher D. Maggiore bought 1,200 shares of ZIVO Bioscience stock. The stock was acquired at an average cost of $21.18 per share, with a total value of $25,416.00. Following the completion of the transaction, the director now directly owns 135,050 shares of the company's stock, valued at $2,860,359. Learn More on Christopher D. Maggiore's trading history.
Who are ZIVO Bioscience's active insiders?: ZIVO Bioscience's insider roster includes Christopher Maggiore (Director), Nola Masterson (Director), and John Payne (Director). Learn More on ZIVO Bioscience's active insiders.

Christopher D. Maggiore Insider Trading History at ZIVO Bioscience

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2022	Buy	1,200	$21.18	$25,416.00	135,050
2/11/2022	Buy	7,494	$23.22	$174,010.68
2/9/2022	Buy	4,727	$21.30	$100,685.10
1/11/2022	Buy	1,260	$15.84	$19,958.40
1/3/2020	Buy	81,687	$0.96	$78,419.52
12/18/2019	Buy	111,420	$0.78	$86,907.60
11/20/2019	Buy	56,671	$0.60	$34,002.60
11/13/2019	Buy	7,500	$0.54	$4,050.00
10/31/2019	Buy	11,666	$0.48	$5,599.68
10/24/2019	Buy	2,500	$0.42	$1,050.00
10/11/2019	Buy	13,750	$0.54	$7,425.00
9/24/2019	Buy	6,666	$0.54	$3,599.64
9/18/2019	Buy	5,016	$0.54	$2,708.64
9/6/2019	Buy	9,166	$0.54	$4,949.64
8/19/2019	Buy	7,500	$0.66	$4,950.00
7/19/2019	Buy	15,833	$0.72	$11,399.76
5/8/2019	Buy	82,666	$0.66	$54,559.56
3/12/2019	Buy	15,000	$0.60	$9,000.00
1/20/2019	Buy	14,233	$0.66	$9,393.78
1/2/2019	Buy	120,750	$0.72	$86,940.00
12/10/2018	Buy	35,500	$0.72	$25,560.00
9/21/2018	Buy	10,281	$1.02	$10,486.62
9/17/2018	Buy	836,166	$0.60	$501,699.60
9/6/2018	Buy	3,000	$0.90	$2,700.00
8/27/2018	Buy	17,000	$0.78	$13,260.00
8/7/2018	Buy	14,166	$0.72	$10,199.52
7/30/2018	Buy	2,500	$0.66	$1,650.00
7/20/2018	Buy	1,666	$0.78	$1,299.48
7/17/2018	Buy	6,666	$0.60	$3,999.60
5/17/2018	Buy	27,166	$0.54	$14,669.64
3/8/2018	Buy	19,333	$0.66	$12,759.78
3/5/2018	Buy	10,000	$0.72	$7,200.00
2/14/2018	Buy	19,333	$0.54	$10,439.82
1/23/2018	Buy	12,333	$0.42	$5,179.86
1/3/2018	Buy	17,166	$0.54	$9,269.64
12/19/2017	Buy	20,833	$0.54	$11,249.82
11/29/2017	Buy	32,833	$0.60	$19,699.80
11/17/2017	Buy	3,333	$0.48	$1,599.84
11/10/2017	Buy	15,500	$0.42	$6,510.00
10/26/2017	Buy	8,333	$0.48	$3,999.84
8/24/2017	Buy	3,333	$0.42	$1,399.86	2,267,138
4/27/2017	Buy	19,000	$0.42	$7,980.00	2,240,638
1/6/2015	Buy	6,511	$0.54	$3,515.94
5/9/2014	Buy	7,900	$1.02	$8,058.00
5/2/2014	Buy	37,500	$1.08	$40,500.00
4/23/2014	Buy	18,294	$1.14	$20,855.16
8/1/2013	Buy	138,888	$0.72	$99,999.36
4/19/2013	Buy	11,283	$2.28	$25,725.24
4/12/2013	Buy	1,366	$1.80	$2,458.80
4/1/2013	Buy	6,166	$1.86	$11,468.76
3/25/2013	Buy	25,866	$1.74	$45,006.84
3/8/2013	Buy	33,500	$1.38	$46,230.00
2/28/2013	Buy	4,250	$1.32	$5,610.00
2/22/2013	Buy	19,733	$1.38	$27,231.54
2/11/2013	Buy	3,333	$1.44	$4,799.52
2/8/2013	Buy	8,433	$1.44	$12,143.52
1/29/2013	Buy	14,583	$1.62	$23,624.46
1/25/2013	Buy	33,520	$1.56	$52,291.20
1/22/2013	Buy	2,666	$1.50	$3,999.00
1/18/2013	Buy	3,083	$1.50	$4,624.50
1/15/2013	Buy	8,750	$1.56	$13,650.00
1/14/2013	Buy	10,000	$1.56	$15,600.00
1/11/2013	Buy	6,250	$1.68	$10,500.00
1/10/2013	Buy	27,166	$1.62	$44,008.92

Christopher D. Maggiore Buying and Selling Activity at ZIVO Bioscience

ZIVO Bioscience Company Overview

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Today's Range

Now: $21.00

$20.50

$21.00

50 Day Range

MA: $18.57

$13.00

$22.00

2 Week Range

Now: $21.00

$0.48

$22.15

Volume

756 shs

Average Volume

3,279 shs

Market Capitalization

$74.55 million

P/E Ratio

N/A

Dividend Yield